Menu

Plant Cell Walls Can Control Growth in the Dark

To maintain an energy-saving growth strategy in the absence of light, seedlings need signals generated by pectin in their cell walls.

Feb 1, 2018
Kerry Grens

DARK SIDE: Plants use different growth mechanisms in dark and light conditions, called skotomorphogenesis and photomorphogenesis, respectively. A new study suggests pectin fragments in the cell wall signal other cells to maintain skotomorphogenesis in darkness. From these results, a model has emerged in which light somehow interrupts this pectin-based signaling so that photomorphogenesis can commence.© JULIA MOORE

EDITOR'S CHOICE IN PLANT BIOLOGY

The paper
S.A. Sinclair et al., “Etiolated seedling development requires repression of photomorphogenesis by a small cell-wall-derived dark signal,” Curr Biol, 27:3403-18.e7, 2017.

Plants don’t always need sunlight to grow. Through a process called skotomorphogenesis, seedlings germinated in the dark—say, too far under the soil surface—will stretch out into long, pale shoots, searching for light. Think of the spindly bean sprouts you might buy at the store, offers Ute Krämer, a plant physiologist at Ruhr-Universität Bochum in Germany. It’s an energy-saving tactic to get plants to the light. Once they do get there, they switch irreversibly to light-driven growth called photomorphogenesis—spreading out their roots and developing their leaves.

Krämer says that while the cellular components governing photomorphogenesis have been understood for decades, the cell-to-cell signaling pathways that determine the change in strategy from dark- to light-driven growth remain a mystery. How are light signals transmitted from the top of the seedling further down the plant so the switch from skoto- to photomorphogenesis can commence?

To find out, Krämer’s team made use of Arabidopsis mutants that use photomorphogenesis even in the dark, ending up with longer roots and fuller, greener leaves than they would through skotomorphogenesis. In these seedlings, the researchers found that pectin, a cell-wall component, had chemical modifications, including more methyl carboxyester groups and less acetylation.

Although the genetics and molecular mechanics of these mutants varied, the unifying theme was pectin alterations, and Krämer reasoned that these were responsible for allowing photomorphogenesis to proceed in the dark. By this logic, normal pectin components might be the signal that wild-type seedlings use to pass information about the absence of light to other cells. To test this idea, the researchers began supplying mutants with normal pectin fragments in their growth medium to see if they could restore skotomorphogenesis.

First they tried adding a chunk of pectin backbone called galacturonic acid, initially as a monomer. But nothing happened. So they tried a dimer. Again, no change. But once they gave the mutant seedlings a trimer of galacturonic acid, voilà—they looked just like normal plants that had been grown in the dark. “We believe that, in the dark, the plants generate this compound, and this compound is recognized by a receptor that then acts [through] signal transduction to repress the ‘light’ type of seedling development,” says Krämer, “and therefore the ‘dark’ type is maintained.”

Henrik Scheller, a cell wall biologist at Lawrence Berkeley National Laboratory, developed one of the mutants Krämer experimented with, though he was not involved in her study. He says pectin is known for its role in responding to pathogens, but he wouldn’t have predicted that it’s also involved in morphogenesis signaling.

“It opens a lot of new questions,” Scheller tells The Scientist. “And it’s not just incremental change in our understanding; it’s really a fundamentally new role for cell walls and cell wall–generated fragments that is very exciting.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.